Trade News

Peptide Therapeutics Contract API Manufacturing Market Projected to Grow Significantly

2025-06-10
Peptide Therapeutics Contract API Manufacturing Market Projected to Grow Significantly

Market projected to grow through 2035, driven by chronic disease prevalence, synthesis technology advances, and increased outsourcing to CMOs.

The global peptide therapeutics contract API manufacturing market is anticipated to demonstrate significant growth through 2035, driven by the rising incidence of chronic and life-threatening diseases such as cancer and metabolic disorders. Pharmaceutical companies are increasingly outsourcing API production, driven by growing regulatory complexity and cost pressures, particularly for specialized and customized peptide drugs. Innovations in peptide synthesis technology, including solid-phase peptide synthesis (SPPS), microwave-aided synthesis, and automated equipment, have transformed production, enabling higher purity, reduced production times, and lower costs. The pre-clinical segment dominated the market in 2025, as CMOs provide specialized services including complex peptide synthesis, analytical method development, and regulatory consultancy crucial for screening new drug candidates.
Read Full Source Article

Hope to become your Partner

Contact us on Telegram for product inquiries, pricing, and orders.

Contact on Telegram
MINSTAR

Shanghai Minstar Chemical Co., Ltd.
RAW API Supplier | Q2 2026 Catalogue.
Shipping from USA and International warehouses.

All products for research use only, not for human or veterinary use, no sales to individuals.

Quick Links

Official Contact

Building 8, No. 1098, Chuansha Road,
Pudong, Shanghai, China

© 2026 Shanghai Minstar Chemical Co., Ltd. All Rights Reserved. | Prices subject to change without notice.